...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: More Exempt Distribution Investments

"Distribution dates stated incorrectly Jan 11, 2023. Should be Jan 11, 2024. ?"

are you sure? Would be odd for it to say"Jan 11" &'stamped for 2024?

 

 

Share
New Message
Please login to post a reply